OKYO
Okyo Pharma·NASDAQ
--
--(--)
--
--(--)
5.42 / 10
Netural
Capital flows are robust (7.37/10), with positive Small and Medium trends outweighing pressures from larger blocks. Analyst sentiment is overwhelmingly bullish, with one Strong Buy rating and a 100% historical win rate. This combination suggests underlying confidence, yet the mismatch between falling price and positive expectations keeps the overall view netural.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionB. Riley Securities
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of OKYO?
- OKYO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.42/10 (Netural).
